Who Qualifies for Yervoy Patient Assistance?
Bristol Myers Squibb (BMS), the maker of Yervoy (ipilimumab), offers the Bristol Myers Squibb Access Support program for financial aid. Eligibility typically requires:
- A confirmed cancer diagnosis where Yervoy is prescribed.
- U.S. residency or citizenship.
- Household income at or below 500% of the Federal Poverty Level (FPL)—for 2024, that's about $75,300 for a single person or $155,500 for a family of four.
- Lack of private insurance coverage for Yervoy, or high out-of-pocket costs after insurance (e.g., copay over $25/month).
- Medicare patients may qualify for copay assistance up to $15,000/year, but not full free drug if income exceeds limits.
Patients with government insurance like Medicaid generally don't qualify for free drug but may get copay help.
How to Apply for Yervoy Financial Aid
Submit via BMS Access Support:
1. Doctor or patient starts online application at bmsaccesssupport.com or calls 1-888-757-2826.
2. Provide proof of income (tax returns, pay stubs), insurance details, and prescription.
3. Approval often within days; benefits last 1 year, renewable.
Co-pay programs like Yervoy CoPay Card cover copays/deductibles up to $15,000/year for commercially insured patients.
What If You Don't Qualify?
- Independent foundations like Patient Access Network (PAN) or CancerCare offer grants for Yervoy copays if BMS denies—check panfoundation.org.
- GoodRx discounts can drop cash price to ~$10,000/dose vs. list ~$30,000.
- State programs or 340B hospitals provide additional aid.
For latest details, visit bmsaccesssupport.com or drugpatentwatch.com for pricing context.[1]
[1] https://bmsaccesssupport.com
[2] https://www.drugpatentwatch.com/p/tradename/YERVOY